International Research Consortium on Dengue Risk Assessment, Management, and Surveillance
NCT ID: NCT01550016
Last Updated: 2016-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
7411 participants
OBSERVATIONAL
2011-10-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
New Tools for Predicting Capillary Leak Shock During Dengue Fever
NCT04422782
Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever
NCT02134652
Bedside Ultrasound Predicts Progression of Severity of Disease in Dengue Fever
NCT03632486
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Heat Stroke
NCT05155358
Prevalence of Hyponatremia in Dengue Infected Patients: Relationship With Systemic Inflammation.
NCT06109532
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Febrile Patients
Observation of patients with possible dengue fever in the early phase of disease
Observation
Clinical follow-up and laboratory investigations.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Observation
Clinical follow-up and laboratory investigations.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* fever for less than 72 hours
Exclusion Criteria
* not likely to come back for daily follow-up
* complications or signs of severe disease
5 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Union
OTHER
University of Oxford
OTHER
University of Heidelberg Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Jaenisch
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Jänisch
Role: PRINCIPAL_INVESTIGATOR
Heidelberg University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
International Centre for Diarrhoeal Diseases
Dhaka, Dhaka Division, Bangladesh
Fundacao Oswaldo Cruz (FIOCRUZ)
Rio de Janeiro, Rio de Janeiro, Brazil
Fundacao Universidade Estadual do Ceara
Fortaleza, , Brazil
Angkor Hospital for Children
Siem Reap, , Cambodia
Hospital National de Ninos Benjamin Bloom
San Salvador, , El Salvador
Gadjah Madah University
Yogyakarta, , Indonesia
University of Malaya Medical Centre
Kuala Lumpur, , Malaysia
Universidad de Carabobo
Valencia, Valencia, Venezuela
Oxford University Clinical Research Unit
Ho Chi Minh City, , Vietnam
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jaenisch T, Tam DT, Kieu NT, Van Ngoc T, Nam NT, Van Kinh N, Yacoub S, Chanpheaktra N, Kumar V, See LL, Sathar J, Sandoval EP, Alfaro GM, Laksono IS, Mahendradhata Y, Sarker M, Ahmed F, Caprara A, Benevides BS, Marques ET, Magalhaes T, Brasil P, Netto M, Tami A, Bethencourt SE, Guzman M, Simmons C, Quyen NT, Merson L, Dung NT, Beck D, Wirths M, Wolbers M, Lam PK, Rosenberger K, Wills B. Clinical evaluation of dengue and identification of risk factors for severe disease: protocol for a multicentre study in 8 countries. BMC Infect Dis. 2016 Mar 11;16:120. doi: 10.1186/s12879-016-1440-3.
Related Links
Access external resources that provide additional context or updates about the study.
IDAMS consortium
Section Clinical Tropical Medicine, Heidelberg University Medical Center, Germany
Oxford University Clinical Research Unit, Viet Nam
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
281803 (EU FP7-HEALTH-2011)
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.